KEEPBIO
Reset the Microbiome.
Redefine Infection Prevention.
Many healthcare-associated infections are linked to disruption of the gut microbiome following antibiotic treatment in vulnerable patients. KeepBio helps rebuild a healthy gut microbiome to support its natural protective functions.
About KeepBio
More than 100,000 people in the U.S. die each year from healthcare-associated infections. Growing evidence suggests that disruption of the protective gut microbiome during antibiotic treatment may contribute to infection risk in vulnerable patients.
KeepBio’s technology was developed to help close this nutritional gap with a proprietary, human-milk-inspired medical nutrition therapy designed to support restoration of the gut microbiome following antibiotic treatment. It is intended to be used alongside antibiotics—not in place of them.
Our vision is to make microbiome restoration a routine part of antibiotic care for the tens of millions of patients who receive antibiotics every year.
Opportunity & Collaboration
Advacing Microbiome-Based Infection Prevention
Keepbio is addressing a significant clinical and economic challenge in vulnerable patients exposed to antibiotics.
Explore our initial focus in critical care and leukemia, the broader platform opportunity, and ways to collaborate in clinical research and development.